Quarterly report pursuant to Section 13 or 15(d)

Statement of Cash Flows

v3.19.3
Statement of Cash Flows - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:              
Net loss $ (736,080) $ (1,376,235) $ (890,461) $ (640,184) $ (876,347) $ (3,018,015) $ (2,337,471)
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock compensation expense (non-cash) 242,956 233,776 232,992 93,244 114,526 734,365 296,340
Changes in operating assets and liabilities, net              
Other current assets           (4,631) (120,170)
Accounts payable, accrued expenses and other current liabilities           (60,695) 26
Net cash used in operating activities           (2,348,975) (2,161,275)
Cash flows from financing activities:              
Deferred offering costs           (39,458) 0
Net cash provided by financing activities           (39,458) 0
Effect of exchange rates on cash, cash equivalents, and restricted cash           (9,799) (2,385)
Net decrease in cash, cash equivalents, and restricted cash           (2,398,232) (2,163,660)
Cash, cash equivalents and restricted cash at beginning of period   $ 6,892,772 7,618,265   $ 9,781,925 6,892,772 9,781,925
Cash, cash equivalents and restricted cash at end of period $ 4,494,540   $ 6,892,772 $ 7,618,265   $ 4,494,540 $ 7,618,265